Loading viewer...
investor_presentation
Format: PDF investor_presentation
Suven Pharmaceuticals Q1 FY25 investor presentation covering operating and financial performance, combined business proforma metrics, and strategic initiatives including the Sapala acquisition and merger update with Cohance Lifesciences. The deck outlines segment-wise strategy and financial performance for the quarter.
investor_presentation
11 Pages
investor_presentation
35 Pages
LUX Industries Limited
Western Midstream Partners Meritage Acquisition 2023
investor_presentationinvestor_presentation
7 Pages
Western Midstream Partners